Tumors Hematopoètics i Limfoides

• Correlacions clinicobiològiques en tumors linfoides
• Al·loreactivitat i quimerisme
• Malaltia mínima residual
• Noves dianes terapèutiques
• Infeccions en malalts neutropènics
• Limfomes posttransplantment d’òrgan sòlid
• Leucèmies agudes
• Síndromes mieloproliferatives cròniques

Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP-EBMT study

Bazarbachi A., Boumendil A., Finel H., Castagna L., Dominietto A., Blaise D., Diez-Martin J.L., Tischer J., Gülbas Z., Wallet H.L., Corral L.L., Mohty M., Koc Y., Yakoub-Agha I., Schmid C., El Cheikh J., Arat M., Forcade E.,

BRITISH JOURNAL OF HAEMATOLOGY (ISSN: 1365-2141) 2020

Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.

Domingo-Domènech E, Boumendil A, Climent F, Socié G, Kroschinsky F, Finel H, Vandenbergue E, Nemet D, Stelljes M, Bittenbring JT, Robinson S, Montoto S, Sureda A, Dreger P, Lymphoma Working Party of the

BONE MARROW TRANSPLANTATION (ISSN: 0268-3369) 2020

Is this real life? Is this just fantasy? Decreased relapse following haploidentical transplant in Hodgkin's lymphoma with posttransplant cyclophosphamide.

Mussetti A, Sureda A

BONE MARROW TRANSPLANTATION (ISSN: 0268-3369) 2020

Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor.

Sureda A, Chabannon C, Masszi T, Pohlreich D, Scheid C, Thieblemont C, Wahlin BE, Sakellari I, Russell N, Janikova A, Dabrowska-Iwanicka A, Touzeau C, Esquirol A, Jantunen E, van der Werf S, Bosman P, Boumendil A, Liu Q, Celanovic M, Montoto S, Dreger P

BONE MARROW TRANSPLANTATION (ISSN: 0268-3369) 2020

Long-term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first-line therapy: A retrospective analysis from two institutions.

Mercadal S, Sancho JM, Climent F, Tapia G, Pomares H, Carro I, Sorigué M, Pané M, Domingo-Doménech E, Encuentra M, Aguilera C, Oliveira AC, Andrade M, Fernández de Sevilla A, Ribera JM, González-Barca E, Sureda A

EUROPEAN JOURNAL OF HAEMATOLOGY (ISSN: 1600-0609) 2020

Improving outpatient follow-up after CAR T-cells therapy: patient real-time monitoring through wearable devices and QoL assessment performed with the use of a digital platform

Mussetti, Alberto (Principal investigator (PI))

Funder:

• GILEAD SCIENCES SI

12/12/2019 - 11/12/2021

Programa de formacion continuada en hematologia 2019

Sureda Balari, Ana Maria (Principal investigator (PI))

Funder reference :

• CPAT-19/027

24/1/2019 -

Patient characteristics, treatment patterns, and clinical outcomes in front-line setting/treatment-naïve patients with hodgkin’s lymphoma

Domingo Domenech, Eva (Principal investigator (PI))

Funder reference :

• TAK-QUI-2018-01 (HL-RCR)

12/2/2019 - 12/2/2022

Postoperaive outcomes within an enhanced recovery after surgery protocol (power.2) national audit of complications following elective total hip or knee replacement within or without an enhanced recovery after surgery

Parody Porras, Rocio (Principal investigator (PI))

Funder reference :

• GCP# 05.01.020

30/1/2019 -

Estudio observacional retrospectivo del tratamiento de la leucemia linfocítica crónica (LLC) con Ibrutinib en la práctica clínica habitual (IBRORS-LLC)

Oliveira Ramos, Ana Carla(Principal investigator (PI))

Funder reference :

• JAN-IBR-2018-01//54179060CLL4011

4/1/2019 -

• Coordinació del consorci europeu IT-LIVER (inhibició de TGF-β en malalties del fetge) - programa de Marie Curie ITN.
• Projectes nacionals (Pla Estatal, FIS), fundacions privades (Marató TV3 i AECC) i projectes amb empreses farmacèutiques (Digna - Espanya, 4SC AG-Alemanya)